Palmer JL - Search Results

1

Trisomy 7: a potential cytogenetic marker of human prostate cancer progression.

Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenbach AC, Chung LW, Liang JC. Bandyk MG, et al. Among authors: palmer jl. Genes Chromosomes Cancer. 1994 Jan;9(1):19-27. doi: 10.1002/gcc.2870090105. Genes Chromosomes Cancer. 1994. PMID: 7507696

2

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.

Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ. Navone NM, et al. Among authors: palmer jl. J Natl Cancer Inst. 1993 Oct 20;85(20):1657-69. doi: 10.1093/jnci/85.20.1657. J Natl Cancer Inst. 1993. PMID: 7692074

3

Trisomy 7 by dual-color fluorescence in situ hybridization: a potential biological marker for prostate cancer progression.

Wang RY, Troncoso P, Palmer JL, El-Naggar AK, Liang JC. Wang RY, et al. Among authors: palmer jl. Clin Cancer Res. 1996 Sep;2(9):1553-8. Clin Cancer Res. 1996. PMID: 9816332

4

Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations.

Zhau HE, Zhao LS, Chung LW, Chen BQ, Troncoso P, Kao C, Kojima M, Fraser Symmans W, Zheng N, Palmer JL, Moul JW, Davis R, Ye MF, Xiao LS, Craig Hall M. Zhau HE, et al. Among authors: palmer jl. Urol Oncol. 1995 Mar-Apr;1(2):51-63. doi: 10.1016/1078-1439(95)00009-7. Urol Oncol. 1995. PMID: 21224092 Free article.

5

p53 and RB expression predict progression in T1 bladder cancer.

Grossman HB, Liebert M, Antelo M, Dinney CP, Hu SX, Palmer JL, Benedict WF. Grossman HB, et al. Among authors: palmer jl. Clin Cancer Res. 1998 Apr;4(4):829-34. Clin Cancer Res. 1998. PMID: 9563875

6

Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors.

Tsao AS, Shin DM, Palmer JL, Lee JS, Glisson BS. Tsao AS, et al. Among authors: palmer jl. Cancer. 2004 May 15;100(10):2240-5. doi: 10.1002/cncr.20238. Cancer. 2004. PMID: 15139070 Free article. Clinical Trial.

7

Analysis of p53 gene deletions in patients with non-Hodgkin's lymphoma by dual-colour fluorescence in-situ hybridization.

Clodi K, Younes A, Goodacre A, Roberts M, Palmer J, Younes M, Cabanillas F, Andreeff M. Clodi K, et al. Br J Haematol. 1997 Sep;98(4):913-21. doi: 10.1046/j.1365-2141.1997.3143131.x. Br J Haematol. 1997. PMID: 9326189 Free article.

8

A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status.

Johnson FM, Garden A, Palmer JL, Kies M, Clayman G, Brumfield B, Khuri FR, Morrison W, Papadimitrakopoulou V, Diaz EM, Glisson BS. Johnson FM, et al. Among authors: palmer jl. Cancer. 2004 Mar 1;100(5):991-8. doi: 10.1002/cncr.20079. Cancer. 2004. PMID: 14983495 Free article. Clinical Trial.

9

Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers.

Bruera E, Bush SH, Willey J, Paraskevopoulos T, Li Z, Palmer JL, Cohen MZ, Sivesind D, Elsayem A. Bruera E, et al. Among authors: palmer jl. Cancer. 2009 May 1;115(9):2004-12. doi: 10.1002/cncr.24215. Cancer. 2009. PMID: 19241420 Free PMC article.

10

The pattern of serum markers in patients with androgen-independent adenocarcinoma of the prostate.

Kim J, Palmer JL, Finn L, Hodges S, Bowes V V, Deftos L, Murphy G, Logothetis C. Kim J, et al. Among authors: palmer jl. Urol Oncol. 2000 Apr 1;5(3):97-103. doi: 10.1016/s1078-1439(99)00047-2. Urol Oncol. 2000. PMID: 10765015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters